Stage IIA Prostate Cancer AJCC v8: Clinical Trials

18 trials for Stage IIA Prostate Cancer AJCC v8, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 active not recruiting, 3 terminated, 2 completed, 2 suspended. 7 Not applicable, 5 Phase 2, 2 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable7Active not recruiting 4, Completed 1, Suspended 1, Withdrawn 1
Phase 25Active not recruiting 3, Suspended 1, Terminated 1
Early Phase 12Recruiting 1, Withdrawn 1
Phase 31Terminated 1

Follow Stage IIA Prostate Cancer AJCC v8: new trials by email Literature Review of Stage IIA Prostate Cancer AJCC v8 trials Research Report on Stage IIA Prostate Cancer AJCC v8

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
Biopsy of Prostate, Decipher Prostate Cancer Test, Flotufolastat F-18 Gallium - Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8
Early Phase 1RecruitingNorthwestern University402023-06-072026-07-02
RElugolix VErsus LeUprolide Cardiac Trial
Radiation therapy, Leuprolide, Relugolix - Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma
Phase 2Active not recruitingEmory University942022-06-062026-02-12
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer
Quality-of-Life Assessment, Questionnaire Administration, Radical Prostatectomy - Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8
Not applicableSuspendedUniversity of Southern California1962021-10-272026-06-01
Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer
Dietary Intervention, Radical Prostatectomy - Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8
Not applicableActive not recruitingM.D. Anderson Cancer Center122021-08-272026-09-18
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA
Clinical Observation, Patient Observation, Questionnaire Administration - Prostate Adenocarcinoma, PSA Failure
Phase 2SuspendedCity of Hope Medical Center1332021-05-102026-08-10
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy
Survey Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8
TerminatedUniversity of Southern California352020-12-182024-04-29
Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial
Discussion, Hypofractionated Radiation Therapy, Laboratory Biomarker Analysis - Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
Not applicableActive not recruitingJonsson Comprehensive Cancer Center2082020-11-102026-07-07
Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer
Computed Tomography, Fluorine F 18 DCFPyL, Positron Emission Tomography - Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8
Phase 3TerminatedJonsson Comprehensive Cancer Center542020-08-142023-01-17
An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer
7 Tesla Magnetic Resonance Imaging - Non-Metastatic Prostate Carcinoma, Stage I Prostate Cancer AJCC v8
Not applicableCompletedUniversity of Southern California202020-08-112025-03-17
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
Patient Monitoring, Questionnaire Administration - Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
CompletedCity of Hope Medical Center222020-08-112026-10-14
Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer
High-Dose Rate Brachytherapy, Quality-of-Life Assessment, Questionnaire Administration - Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
Not applicableWithdrawnJonsson Comprehensive Cancer Center2020-04-032020-11-06
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners
Accelerometer, Ecological Momentary Assessment, Questionnaire Administration - Cancer Survivor, Partner
Active not recruitingM.D. Anderson Cancer Center2002020-02-262026-08-21
Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy
Food Diary, Preventative Dietary Intervention, Questionnaire Administration - Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8
Early Phase 1WithdrawnMayo Clinic2020-01-082022-07-11
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery
EC Aspirin, Radical Prostatectomy, Recombinant Interferon Alfa-2b - Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8
Phase 2Active not recruitingRoswell Park Cancer Institute122019-11-292026-06-09
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans
Exercise Intervention, Informational Intervention, Interview - Cancer Survivor, Partner
Not applicableActive not recruitingM.D. Anderson Cancer Center62019-08-272026-04-15
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer
High-Dose Rate Brachytherapy, Quality-of-Life Assessment, Questionnaire Administration - Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8
Phase 2Active not recruitingRutgers, The State University of New Jersey142019-07-172025-09-17
Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer
Olaparib, Radical Prostatectomy - Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage I Prostate Cancer AJCC v8
Phase 2TerminatedUniversity of Washington22018-09-112020-09-21
Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners
Counseling, Informational Intervention, Quality-of-Life Assessment - Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8
Not applicableActive not recruitingM.D. Anderson Cancer Center642018-01-252026-08-11

Narrower conditions

Prostatic Neoplasms (18)  ·  Carcinoma, Renal Cell (1)  ·  Colorectal Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)  ·  Urogenital Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Genital Diseases (18)  ·  Genital Diseases, Male (18)  ·  Genital Neoplasms, Male (18)  ·  Male Urogenital Diseases (18)  ·  Neoplasms by Site (18)  ·  Prostatic Diseases (18)  ·  Urogenital Diseases (18)  ·  Neoplasms (17)  ·  Urogenital Neoplasms (17)  ·  Adenocarcinoma (1)  ·  Adnexal Diseases (1)  ·  Carcinoma (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)

Interventions

Brachytherapy (3)  ·  Radiosurgery (3)  ·  Magnetic Resonance Spectroscopy (2)  ·  Radiotherapy (2)  ·  2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid (1)  ·  Aspirin (1)  ·  Counseling (1)  ·  Diet Records (1)  ·  Diet Therapy (1)  ·  Ecological Momentary Assessment (1)  ·  Interferon alpha-2 (1)  ·  Interviews as Topic (1)  ·  Introns (1)  ·  Leuprolide (1)  ·  Nutrition Assessment (1)

Sponsors

M.D. Anderson Cancer Center (4)  ·  Jonsson Comprehensive Cancer Center (3)  ·  University of Southern California (3)  ·  City of Hope Medical Center (2)  ·  Emory University (1)  ·  Mayo Clinic (1)  ·  Northwestern University (1)  ·  Roswell Park Cancer Institute (1)  ·  Rutgers, The State University of New Jersey (1)  ·  University of Washington (1)

Countries

United States (18)

Top investigators

Dalnim Cho (2)  ·  Alan C Lee (1)  ·  Amar Kishan (1)  ·  Ashley E Ross (1)  ·  Clayton S Lau (1)  ·  Gurkamal S Chatta (1)  ·  Hooman Djaladat, MD (1)  ·  Jeremie Calais (1)  ·  Justin R Gregg (1)  ·  Kimberly Miller, MD (1)  ·  Laleh Melstrom (1)  ·  Lara Hathout (1)  ·  Lorna McNeill (1)  ·  Mark S Shiroishi, MD (1)  ·  Robert J Karnes (1)

Results publications

PMID 33962579, PMID 38664019, PMID 39390760, PMID 40177325, PMID 41706486, PMID 41833067

NIH funding

P30CA014089 (3), P30CA033572 (2), P30CA015083 (1), P30CA015704 (1), P30CA016672 (1), P30CA060553 (1), P30CA072720 (1), P30CA138292 (1), P50CA140388 (1)